Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SALL4P2 is a pseudogene, a non-coding genomic sequence related to the functional SALL4 gene. It does not encode an active protein or participate in biological functions relevant to therapeutics, drug development, or disease. The canonical SALL4 gene encodes a zinc finger transcription factor critical for embryonic development, stemness, and cancer biology, but SALL4P2 itself is not a direct therapeutic target and currently lacks meaningful biological function or disease association in the literature[1][2][3]. If your intention is to study a therapeutic target, you should refer to “Sal-like protein 4” (SALL4), not SALL4P2. SALL4 is a transcription factor implicated in stem cell maintenance and cancer and is being explored as both a biomarker and therapeutic target[1][2][3]. SALL4P2, by contrast, is not a functional protein-coding gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spalt like transcription factor 4 pseudogene 2 (SALL4P2).